News
CCC Diagnostics and the University of Maryland awarded a second year of MIPS Funding
February 18, 2008 - CCC Diagnostics and the University of Maryland have been awarded
a second year of funding from the Maryland Industrial Partnership in support of
their project “Clinical Studies of the Drug Response Indicator Test
Article from the Baltimore Business Journal
DRIT Clinical Data Presented at 2008 ICACT Meeting
February 8,2008 - Dr. Katherine Tkaczuk of the University of Maryland Greenebaum Cancer Center gave
an oral presentation describing CCC Diagnostics DRIT technology at the 19th International
Congress on Anti-cancer Treatment in Paris, France.
Full Abstract
Presentation
CCC Diagnostics LLC presents poster at San Diego AACR Conference
October 2007 - CCC Diagnostics LLC was invited to present a poster at the
AACR-Special Conference in Cancer Research: Advances in Breast Cancer
Research: Genetics, Biology, and Clinical Applications in San Diego, CA.
2007 AACR San Diego Poster Presentation
The University of Maryland and CCC Diagnostics Receive $410,477 in MIPS Funding
February 2007 - Baltimore-based CCC Diagnostics LLC and the
University of Maryland, Baltimore received $410,477 for clinical
studies of the company's diagnostic service for personalized
chemotherapy,
which measures a tumor's resistance to commonly used cancer
drugs.
Excerpt
University of Maryland Press Release
The University of Maryland and CCC Diagnostics receive MIPS Funding
December 2006 - CCC Diagnostics and Dr. Katherine Tkaczuk of the University of Maryland Greenebaum Cancer Center have been selected to receive a Maryland Industrial Partnership (MIPS) grant for their project “Clinical Studies of the Drug Response Indicator Test”
CCC Diagnostics receives COSAT Funding
October 2006 - CCC Diagnostics LLC has been chosen to receive funding from Johnson and Johnson's Corporate Office of Science and Technology (COSAT) for development of the Drug Response Indicator Test. This funding will be administered as part of TEDCO's Maryland Technology Transfer Fund (MTTF) award.
TEDCO Approves $75,000 award to CCC Diagnostics, LLC
September 2006 - The Maryland Technology Development Corporation (TEDCO) has approved an award of $ 75,000 to CCC Diagnostics, LLC (CCCD) through the Maryland Technology Transfer Fund. The funding will support clinical studies of CCCD's Drug Response Indicator Test (DRIT).
The Drug Response Indicator Test (DRIT) utilizes proprietary platform technology and delivers in one test a detailed profile of the tumor's response rate to 5-7 FDA approved anticancer drugs. Armed with the advanced diagnostics, physicians are able to treat patients more effectively and with greater speed. CCCD's commitment is to "saving lives and life savings."